Wild Type and Gain of Function Mutant TP53 can Regulate the Sensitivity of Pancreatic Cancer Cells to Chemotherapeutic Drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 Pathway Inhibitors, Nutraceuticals and Alter Metabolic Properties
Date
This item will be available on:
Authors
McCubrey, James A.
Meher, Akshaya K.
Akula, Shaw M.
Abrams, Stephen L.
Steelman, Linda S.
LaHair, Michelle M.
Franklin, Richard A.
Martelli, Alberto M.
Ratti, Stefano
Cocco, Lucio
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Keywords
Citation
item.page.doi
10.18632/aging.204038